Prostate cancer and screening - to be or not to be;Blööruhálskirtilskrabbamein og hópleit: Allt orkar tvímælis pá er gert er

Laeknabladid

Volumn 95, Issue 6, 2009, Pages 421-

  Jónsson, Eiríkur ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; ICELAND; MALE; MASS SCREENING; PROSTATE TUMOR;

HUMANS; ICELAND; MALE; MASS SCREENING; PROSTATIC NEOPLASMS;

EID: 67649959412     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate - cancer screening trial. N Engl J Med 2009; 360: 1310-9
2. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and Prostate-Cancer Mortality in a Randomized European Study. N Engl J Med 2009; 360: 1320-8.
3. Tryggvadottir L, Vidarsdóttir L, Thorgeirsson T, et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 2007; 99; 929-35.
4. Gudmundsson J, Sulem P, Manolescu A, et al. Genomewide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631-7.